Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 3Phase 3 2Phase 1/2 2Phase 2/3 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia 2Recurrence 1Burkitt Lymphoma 1

Interventions

Dexamethasone 8Cytarabine 7Cyclophosphamide 7venetoclax 6Vincristine 6Methotrexate 5merphos 4Rituximab 4Prednisone 4pegaspargase 3fludarabine phosphate 3dexamethasone acetate 3dexamethasone 21-phosphate 3Peripheral Blood Stem Cell Transplantation 3Filgrastim 3Calcium Dobesilate 3ruxolitinib 2prednylidene 2nelarabine 2deltacortene 2auricularum 2Whole-Body Irradiation 2Specimen Handling 2Pentetic Acid 2Mycophenolic Acid 2Injections 2Granulocyte Colony-Stimulating Factor 2Everolimus 2Etoposide 2Decitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × nelarabine × Clear all
NCT03808610 2026-05-13

Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

M.D. Anderson Cancer Center

Phase 1/2 Terminated
53 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00981799 2020-10-01

Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1/2 Terminated
23 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡